Phase 1 dose escalation and expansion safety study of BLZ-100 in pediatric subjects with primary central nervous system tumors.
Year: 2016
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Dennis Michael Miller, Amy Lee, Jeff Ojemann, Bonnie Cole, Sandra Poliachik, Laura Ishak, Stacey Hansen, Julie Novak, Sarah Leary
Institutions: Blaze Bioscience (United States), Seattle Children's Hospital
Language: English
Subfield: Genetics
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2891406325
